Loading provider…
Loading provider…
Medical Oncology Physician in Chicago, IL
NPI: 1003087768Primary Practice Location
RUSH UNIVERSITY MEDICAL CENTER
1620 W Harrison St, Chicago, IL
Primary Employer
Rush University Internists
rush.edu
HQ Phone
Get MD Marta's Phone NumberMobile
Get MD Marta's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
2005 - 2026

American Board of Internal Medicine
Medical Oncology
Rush University Medical Center
Fellowship • Hematology and Medical Oncology
2005 - 2008
Residency • Internal Medicine
2002 - 2005
Rush Medical College
rushu.rush.edu
Medical School
Until 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 243 | 701 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 58 | 67 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 37 | 37 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 24 | 26 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 16 | 29 |
The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients
Authors: Philip Bonomi, Mary Fidler
Publication Date: 2018-03
The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.
Authors: Steven Gitelis, Charles Gusho, Mia Weiss, Dian Wang, Alan Blank
Journal: Acta Oncol
Publication Date: 2021-10-22
Authors: Matthew Colman, Steven Gitelis, Alan Blank
Journal: J Surg Oncol
Publication Date: 2022-01-13
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Paclitaxel, PROCEDURE: Computed Tomography, DRUG: Cabozantinib S-malate, PROCEDURE: FDG-Positron Emission Tomography
Lead Sponsor: Inhibrx Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: INBRX-109
Lead Sponsor: Rush University Medical Center
Collaborators: AstraZeneca
Intervention / Treatment: DRUG: Durvalumab